| Breakdown | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 1.89B | 2.03B | 2.08B | 3.54B | 3.67B |
| Gross Profit | 1.02B | 1.06B | 1.03B | 1.08B | 1.12B |
| EBITDA | 405.56M | 182.38M | 177.28M | 294.23M | 251.96M |
| Net Income | 144.70M | 10.24M | -385.63M | 36.94M | 3.51M |
Balance Sheet | |||||
| Total Assets | 3.17B | 3.40B | 4.27B | 4.74B | 4.96B |
| Cash, Cash Equivalents and Short-Term Investments | 297.12M | 486.10M | 622.22M | 681.15M | 746.92M |
| Total Debt | 2.22B | 2.05B | 2.30B | 2.57B | 2.56B |
| Total Liabilities | 3.97B | 3.98B | 4.64B | 4.68B | 4.85B |
| Stockholders Equity | -802.36M | -578.43M | -368.58M | 60.65M | 112.63M |
Cash Flow | |||||
| Free Cash Flow | 299.71M | 156.77M | -23.41M | 51.14M | 117.47M |
| Operating Cash Flow | 365.99M | 229.17M | 79.47M | 175.98M | 301.51M |
| Investing Cash Flow | -125.10M | -49.06M | -122.83M | -24.27M | -155.25M |
| Financing Cash Flow | -428.09M | -305.45M | -31.27M | -198.08M | -330.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
73 Outperform | $90.99B | 21.35 | 15.87% | 1.94% | 3.09% | 14.94% | |
69 Neutral | $22.08B | 38.11 | 15.79% | 0.89% | -1.60% | 4.87% | |
66 Neutral | $19.36B | 24.39 | 35.40% | 1.02% | 12.54% | 19.59% | |
66 Neutral | $98.46B | 17.69 | 33.83% | 6.55% | -1.25% | -2.25% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% | |
58 Neutral | $1.61B | 12.83 | ― | 2.82% | -35.52% | ― | |
58 Neutral | $5.55B | 49.19 | 14.41% | 2.56% | -0.74% | -32.79% |
On March 2, 2026, Pitney Bowes Inc. completed a $150 million private offering of 7.250% Senior Notes due 2029 as an add-on to its existing 2029 notes, bringing the total outstanding in this series to $476 million. The senior unsecured notes, guaranteed by certain U.S. subsidiaries and bearing semi-annual interest, were sold to qualified institutional buyers under Rule 144A and issued under an existing indenture as supplemented for this transaction.
The company received approximately $146.9 million in net proceeds after discounts and expenses and plans to use the funds for general corporate purposes, including repaying, repurchasing or refinancing other debt. The new issuance strengthens Pitney Bowes’ liquidity and capital structure flexibility, while subjecting the company and key subsidiaries to customary covenants and default provisions tied to its broader debt arrangements.
The most recent analyst rating on (PBI) stock is a Buy with a $12.50 price target. To see the full list of analyst forecasts on Pitney Bowes stock, see the PBI Stock Forecast page.
On February 25, 2026, Pitney Bowes Inc. said it planned a private placement of an additional $200 million of its 7.250% Senior Notes due March 15, 2029, to be issued as a single series with its existing 7.250% Senior Notes first sold on March 19, 2021. The notes, which carry a 7.250% annual coupon and are senior unsecured obligations guaranteed by certain wholly owned U.S. subsidiaries, are intended to bolster general corporate liquidity and support repayment, repurchase or refinancing of other indebtedness, potentially reshaping the company’s capital structure and debt maturity profile.
The most recent analyst rating on (PBI) stock is a Buy with a $12.50 price target. To see the full list of analyst forecasts on Pitney Bowes stock, see the PBI Stock Forecast page.
On December 22, 2025, Pitney Bowes announced that its cash tender offers for its 6.70% Notes due 2043 and 5.250% Medium-Term Notes due 2037 had expired, following an increase in the maximum aggregate principal amount to be purchased from $75 million to $80 million. The offers, which expired on December 19, 2025, resulted in approximately $79.9 million in aggregate principal amount of notes being validly tendered and not withdrawn, allowing the company to accept all tendered notes without proration, effectively retiring a portion of its long-dated debt and refining its capital structure.
The most recent analyst rating on (PBI) stock is a Hold with a $11.00 price target. To see the full list of analyst forecasts on Pitney Bowes stock, see the PBI Stock Forecast page.